期刊
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
卷 16, 期 2, 页码 80-82出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41575-018-0094-6
关键词
-
资金
- EPoS (Elucidating Pathways of Steatohepatitis) consortium - Horizon 2020 Framework Program of the European Union [634413]
In 2018, there have been substantial advances in our understanding of the risk factors for advanced liver disease in nonalcoholic fatty liver disease, including genetic variants and the gut microbiota. Promising results have also arisen from drugs targeting metabolic pathways involved in the progression of liver damage.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据